Companies
Bharat Biotech’s Covaxin phase 3 trials efficacy data approved by SEC
Bharat Biotech phase 3 trials efficacy data has been approved by the Subject Expert Committee (SEC). As per CNBC TV18…
Tag
approval
Companies